Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Copaxone®
26.08.2024
Molecular and Cell Biology, Immunology, Disease, Drugs & Diagnostics, Diagnostic Techniques and Drugs
Weizmann Institute researchers reveal how Copaxone protects the heart muscle and improves its function after a heart attack
03.05.2023
Focusing on the ups and downs of multiple sclerosis, Weizmann Institute researchers discover a major player in its remission
27.05.2022
A preeminent scientist and the sixth President of the Weizmann Institute of Science
10.10.2010
from the institute to Teva Pharmaceuticals Ltd.
12.09.2010
In the 1950s, Prof. Ephraim Katzir developed simple synthetic models, known as polyamino acids, that...
01.10.2009
Professor Ephraim Katzir passed away on Saturday, May 30, 2009
01.05.2009
From student to Institute Vice President
10.10.2007
Israeli scientists identify: Genes that Affect Responses of Multiple Sclerosis Patients to Copaxone®
...
01.01.2002
One in every hundred adults in the Western world suffers from chronic glaucoma, a disease that causes blindness. Prof. Michal Schwartz,...
01.05.2001
Institute scientists halt progressive eyesight loss in animals afflicted with a glaucoma-like disease
